ArticleEClinicalMedicine2021

Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data.

Nicholas Swart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.